Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Certain drugs that block specific enzymes can help treat prostate diseases.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Finasteride in male rats causes liver and metabolic issues in their offspring.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Balanced vitamin D levels are crucial to delay aging and prevent related diseases.

Cytochrome P-450 enzymes in the skin help break down various substances and could be targeted to treat skin conditions.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Climate-related nutritional stress may cause hair loss in juvenile male Guadalupe fur seals.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.